{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:17:33Z","timestamp":1794651453122,"version":"4.9.1"},"reference-count":108,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":5088,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2002,1]]},"DOI":"10.1046\/j.1523-1755.2002.00085.x","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T10:00:06Z","timestamp":1027677606000},"page":"1-9","source":"Crossref","is-referenced-by-count":82,"title":["Immunoglobulin light chain amyloidosis and the kidney"],"prefix":"10.1016","volume":"61","author":[{"given":"Morie A.","family":"Gertz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha Q.","family":"Lacy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Dispenzieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s004280050211","article-title":"Diagnosis and immunohistochemical classification of systemic amyloidoses. Report of 43 cases in an unselected autopsy series","volume":"433","author":"Strege","year":"1998","journal-title":"Virchows Arch"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0015","first-page":"6","article-title":"A molecular model of the amyloid fibril","volume":"199","author":"Blake","year":"1996","journal-title":"Ciba Found Symp"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0020","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1056\/NEJM197402282900902","article-title":"Patterns of amyloidosis and their association with plasma-cell dyscrasia, monoclonal immunoglobulins and Bence-Jones proteins","volume":"290","author":"Isobe","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0025","first-page":"45","article-title":"Primary systemic amyloidosis: Clinical and laboratory features in 474 cases","volume":"32","author":"Kyle","year":"1995","journal-title":"Semin Hematol"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0030","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF00433586","article-title":"Morphological and clinical features of renal amyloidosis","volume":"366","author":"Watanabe","year":"1975","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0035","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s004280050471","article-title":"Highly sensitive diagnosis of amyloid and various amyloid syndromes using Congo red fluorescence","volume":"436","author":"Linke","year":"2000","journal-title":"Virchows Arch"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0040","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/206737a0","article-title":"Structure of amyloid fibrils after negative staining and high-resolution electron microscopy","volume":"206","author":"Shirahama","year":"1965","journal-title":"Nature"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0045","first-page":"461","article-title":"The association of amyloid P-component (AP) with the amyloid fibril: An updated method for amyloid fibril protein isolation","volume":"12","author":"Skinner","year":"1982","journal-title":"Prep Biochem"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0050","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0889-8588(05)70417-2","article-title":"Biology and therapy of immunoglobulin deposition diseases","volume":"11","author":"Dhodapkar","year":"1997","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0055","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/0006-291X(70)90227-5","article-title":"An amyloid protein: The amino-terminal variable fragment of an immunoglobulin light chain","volume":"41","author":"Glenner","year":"1970","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0060","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.174.4010.712","article-title":"Creation of \u201camyloid\u201d fibrils from Bence Jones proteins in vitro","volume":"174","author":"Glenner","year":"1971","journal-title":"Science"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0065","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1046\/j.1365-2249.1999.00939.x","article-title":"Structural relationship of kappa-type light chains with AL amyloidosis: Multiple deletions found in a V\u03baIV protein","volume":"118","author":"Alim","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0070","first-page":"409","article-title":"Diagnostic approach to and follow-up of difficult cases of AL amyloidosis","volume":"80","author":"Perfetti","year":"1995","journal-title":"Haematologica"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0075","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1172\/JCI110635","article-title":"Bence Jones proteins and light chains of immunoglobulins. Preferential association of the V lambda VI subgroup of human light chains with amyloidosis AL (lambda)","volume":"70","author":"Solomon","year":"1982","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0080","first-page":"148","article-title":"Clinical aspects of multiple myeloma and related disorders including amyloidosis","volume":"47","author":"Kyle","year":"1999","journal-title":"Pathol Biol"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0085","first-page":"33","article-title":"Classification of amyloidosis by the detection of clonal excess of plasma cells in the bone marrow","volume":"118","author":"Gertz","year":"1991","journal-title":"J Lab Clin Med"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0090","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/(SICI)1097-0142(19980415)82:8<1501::AID-CNCR11>3.0.CO;2-8","article-title":"Primary systemic amyloidosis with delayed progression to multiple myeloma","volume":"82","author":"Rajkumar","year":"1998","journal-title":"Cancer"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0095","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1182\/blood.V79.7.1817.1817","article-title":"Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989","volume":"79","author":"Kyle","year":"1992","journal-title":"Blood"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0100","first-page":"264","article-title":"Case 3\u20132000","volume":"342","author":"Case records of the Massachusetts General Hospital","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0105","first-page":"943","article-title":"Case 38\u20131992","volume":"327","author":"Case records of the Massachusetts General Hospital","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0110","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0002-8703(72)90373-0","article-title":"Postural hypotension in amyloid disease","volume":"84","author":"Gaan","year":"1972","journal-title":"Am Heart J"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0115","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1161\/01.CIR.34.5.883","article-title":"Orthostatic hypotension as a clue to primary systemic amyloidosis","volume":"34","author":"Kyle","year":"1966","journal-title":"Circulation"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0120","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1046\/j.1365-2362.1999.00478.x","article-title":"Echocardiographic features of primary, secondary and familial amyloidosis","volume":"29","author":"Moyssakis","year":"1999","journal-title":"Eur J Clin Invest"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0125","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1093\/clinchem\/37.6.1122","article-title":"Kappa\/lambda index for confirming urinary free light chain in amyloidosis AL and other plasma cell dyscrasias","volume":"37","author":"Levinson","year":"1991","journal-title":"Clin Chem"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0130","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/1040-8428(94)00135-G","article-title":"Diagnosis and treatment of primary amyloidosis","volume":"19","author":"Pacali","year":"1995","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0135","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/ajcp\/96.1.95","article-title":"The predictive value of bone marrow morphologic characteristics and immunostaining in primary (AL) amyloidosis","volume":"96","author":"Wu","year":"1991","journal-title":"Am J Clin Pathol"},{"issue":"Suppl 1","key":"10.1046\/j.1523-1755.2002.00085.x_bb0140","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000168195","article-title":"Proteinuria in multiple myeloma and related diseases","volume":"10","author":"Ganeval","year":"1990","journal-title":"Am J Nephrol"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0145","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1182\/blood.V81.2.564.564","article-title":"Bence Jones protein in primary systemic amyloidosis (letter to the editor)","volume":"81","author":"Pascali","year":"1993","journal-title":"Blood"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0150","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0140-6736(88)92235-0","article-title":"Diagnostic radionuclide imaging of amyloid: biological targeting by circulating human serum amyloid P component","volume":"1","author":"Hawkins","year":"1988","journal-title":"Lancet"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0155","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1056\/NEJM199008233230803","article-title":"Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component","volume":"323","author":"Hawkins","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0160","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3109\/03009749509095175","article-title":"Diagnosing amyloidosis","volume":"24","author":"Westermark","year":"1995","journal-title":"Scand J Rheumatol"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0165","first-page":"68","article-title":"Amyloidosis: current approaches for diagnosis and treatment","volume":"90","author":"Reed","year":"1992","journal-title":"J Ky Med Assoc"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0170","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00000372-199702000-00008","article-title":"Diagnostic screening of systemic amyloidosis by abdominal fat aspiration: an analysis of 100 cases","volume":"19","author":"Masouye","year":"1997","journal-title":"Am J Dermatopathol"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0175","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1600-0714.1997.tb00010.x","article-title":"Amyloid deposits in labial salivary glands identified by electron microscopy","volume":"26","author":"Delgado","year":"1997","journal-title":"J Oral Pathol Med"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0180","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1001\/archinte.1988.00380040169024","article-title":"Utility of subcutaneous fat aspiration for the diagnosis of systemic amyloidosis (immunoglobulin light chain)","volume":"148","author":"Gertz","year":"1988","journal-title":"Arch Intern Med"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0185","first-page":"357","article-title":"Demonstration and classification of amyloidosis in needle biopsies of the kidneys, with special reference to amyloidosis of the AA-type","volume":"95","author":"Lofberg","year":"1987","journal-title":"Acta Pathol Microbiol Immunol Scand [A]"},{"issue":"Suppl 9","key":"10.1046\/j.1523-1755.2002.00085.x_bb0190","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/ndt\/11.supp9.63","article-title":"Clinical and therapeutic aspects of renal amyloidosis","volume":"11","author":"Schena","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0195","first-page":"319","article-title":"Nephrotic syndrome in the elderly","volume":"16","author":"Cameron","year":"1996","journal-title":"Semin Nephrol"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0200","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0002-9343(98)00037-0","article-title":"Prognosis of patients with primary systemic amyloidosis who present with dominant neuropathy","volume":"104","author":"Rajkumar","year":"1998","journal-title":"Am J Med"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0205","first-page":"313","article-title":"Prognostic value of urinary protein in primary systemic amyloidosis (AL)","volume":"94","author":"Gertz","year":"1990","journal-title":"Am J Clin Pathol"},{"issue":"Suppl 59","key":"10.1046\/j.1523-1755.2002.00085.x_bb0210","first-page":"S21","article-title":"Pathogenesis of edema formation in the nephrotic syndrome","volume":"51","author":"Palmer","year":"1997","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0215","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00000441-199307000-00013","article-title":"Nephrotic edema\u2014pathogenesis and treatment","volume":"306","author":"Palmer","year":"1993","journal-title":"Am J Med Sci"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0220","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/ki.1985.179","article-title":"Preservation of blood volume during edema removal in nephrotic subjects","volume":"28","author":"Geers","year":"1985","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0225","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1055\/s-2008-1058661","article-title":"Therapeutic bilateral renal artery embolization in the nephrotic syndrome","volume":"119","author":"Duda","year":"1994","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0230","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1136\/pgmj.69.815.672","article-title":"Renal replacement therapy in multiple myeloma and systemic amyloidosis","volume":"69","author":"Brown","year":"1993","journal-title":"Postgrad Med J"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0235","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1001\/archinte.1992.00400230061010","article-title":"Dialysis support of patients with primary systemic amyloidosis. A study of 211 patients","volume":"152","author":"Gertz","year":"1992","journal-title":"Arch Intern Med"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0240","first-page":"81","article-title":"Chronic dialysis in patients with systemic amyloidosis: the experience in northern Italy","volume":"38","author":"Moroni","year":"1992","journal-title":"Clin Nephrol"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0245","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1053\/ajkd.2000.16205","article-title":"AL-amyloidosis of the kidney initially presenting as minimal change glomerulonephritis","volume":"36","author":"Hetzel","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0250","doi-asserted-by":"crossref","first-page":"851","DOI":"10.2214\/ajr.129.5.851","article-title":"Radiologic findings in renal amyloidosis","volume":"129","author":"Ekelund","year":"1977","journal-title":"Am J Roentgenol"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0255","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/ndt\/13.6.1438","article-title":"Long-term outcome according to renal histological lesions in 118 patients with monoclonal gammopathies","volume":"13","author":"Montseny","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0260","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF01477286","article-title":"Nephrotic syndrome and renal insufficiency in association with amyloidosis: A correlation between structure and function","volume":"59","author":"von Gise","year":"1981","journal-title":"Klin Wochenschr"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0265","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/019131200281273","article-title":"Glomerulopathies with fibrillary deposits","volume":"24","author":"King","year":"2000","journal-title":"Ultrastruct Pathol"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0270","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0889-8588(18)30347-2","article-title":"Mechanisms of disease: monoclonal immunoglobulin deposition. Amyloidosis, light chain deposition disease, and light and heavy chain deposition disease","volume":"6","author":"Buxbaum","year":"1992","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0275","first-page":"281","article-title":"Renal disease and patient survival in light chain deposition disease","volume":"43","author":"Pozzi","year":"1995","journal-title":"Clin Nephrol"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0280","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000040954","article-title":"A patient with multiple myeloma, amyloidosis and light-chain deposition disease in kidneys with a long survival","volume":"101","author":"Christou","year":"1999","journal-title":"Acta Haematol"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0285","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0002-9149(97)82785-3","article-title":"Symptomatic conduction system disease in cardiac amyloidosis","volume":"80","author":"Mathew","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0290","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/qjmed\/91.2.141","article-title":"The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement","volume":"91","author":"Dubrey","year":"1998","journal-title":"Quart J Med"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0295","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0049-0172(05)80006-X","article-title":"Amyloidosis: prognosis and treatment","volume":"24","author":"Gertz","year":"1994","journal-title":"Semin Arthritis Rheum"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0300","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0002-9149(97)00653-X","article-title":"Features and prognosis of exertional syncope in light-chain associated AL cardiac amyloidosis","volume":"80","author":"Chamarthi","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0305","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/0735-1097(96)00202-1","article-title":"Doppler index combining systolic and diastolic myocardial performance: Clinical value in cardiac amyloidosis","volume":"28","author":"Tei","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0310","first-page":"218","article-title":"The degrees of plasma cell clonality and marrow infiltration adversely influence the prognosis of AL amyloidosis patients","volume":"84","author":"Perfetti","year":"1999","journal-title":"Haematologica"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0315","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0095-4543(21)00814-9","article-title":"Nephrotic syndrome","volume":"6","author":"Nagar","year":"1979","journal-title":"Prim Care"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0320","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1182\/blood.V77.2.257.257","article-title":"Response rates and survival in primary systemic amyloidosis","volume":"77","author":"Gertz","year":"1991","journal-title":"Blood"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0325","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood.V93.3.1062","article-title":"Long-term survival (10 years or more) in 30 patients with primary amyloidosis","volume":"93","author":"Kyle","year":"1999","journal-title":"Blood"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0330","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1182\/blood.V52.4.818.818","article-title":"Primary systemic amyloidosis: Comparison of melphalan and prednisone versus placebo","volume":"52","author":"Kyle","year":"1978","journal-title":"Blood"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0335","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1056\/NEJM199704243361702","article-title":"A trial of three regimens for primary amyloidosis: Colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine","volume":"336","author":"Kyle","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0340","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0002-9343(97)89487-9","article-title":"Treatment of 100 patients with primary amyloidosis: A randomized trial of melphalan, prednisone, and colchicine versus colchicine only","volume":"100","author":"Skinner","year":"1996","journal-title":"Am J Med"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0345","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0002-9149(99)00832-2","article-title":"Five or more years of survival in patients with primary systemic amyloidosis and biopsy-proven cardiac involvement","volume":"85","author":"Grogan","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0350","doi-asserted-by":"crossref","first-page":"481","DOI":"10.7326\/0003-4819-125-6-199609150-00009","article-title":"Resolution of heart failure in patients with AL amyloidosis","volume":"125","author":"Dubrey","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0355","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0272-6386(96)90314-5","article-title":"Twenty-one years survival with systemic AL-amyloidosis","volume":"28","author":"Goldsmith","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0360","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/archinte.1990.00390150115022","article-title":"Acute leukemia and cytogenetic abnormalities complicating melphalan treatment of primary systemic amyloidosis","volume":"150","author":"Gertz","year":"1990","journal-title":"Arch Intern Med"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0365","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ajh.2830340112","article-title":"Phase II trial of alpha-tocopherol (vitamin E) in the treatment of primary systemic amyloidosis","volume":"34","author":"Gertz","year":"1990","journal-title":"Am J Hematol"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0370","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ajh.2830440210","article-title":"Phase II trial of recombinant interferon alfa-2 in the treatment of primary systemic amyloidosis","volume":"44","author":"Gertz","year":"1993","journal-title":"Am J Hematol"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0375","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3109\/10428199709059690","article-title":"Treatment of AL-amyloidosis with dexamethasone plus alpha interferon","volume":"27","author":"Dhodapkar","year":"1997","journal-title":"Leuk Lymphoma"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0380","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/BF02785843","article-title":"Phase II trial of high-dose dexamethasone for untreated patients with primary systemic amyloidosis","volume":"16","author":"Gertz","year":"1999","journal-title":"Med Oncol"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0385","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/(SICI)1096-8652(199906)61:2<115::AID-AJH7>3.0.CO;2-I","article-title":"Phase II trial of high-dose dexamethasone for previously treated immunoglobulin light-chain amyloidosis","volume":"61","author":"Gertz","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0390","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/bjc.1998.577","article-title":"The treatment of nephrotic syndrome caused by primary (light chain) amyloid with vincristine, doxorubicin and dexamethasone","volume":"78","author":"Wardley","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0395","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1182\/blood.V93.3.1112","article-title":"Treatment of AL amyloidosis with 4\u2032-iodo-4\u2032-deoxydoxorubicin: an update (letter to the editor)","volume":"93","author":"Merlini","year":"1999","journal-title":"Blood"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0400","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1182\/blood.V86.3.855.855","article-title":"New drug therapy of amyloidoses: resorption of AL-type deposits with 4\u2032-iodo-4\u2032-deoxydoxorubicin","volume":"86","author":"Gianni","year":"1995","journal-title":"Blood"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0405","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/S0002-9440(10)65065-1","article-title":"4\u2032-Iodo-4\u2032-deoxydoxorubicin disrupts the fibrillar structure of transthyretin amyloid","volume":"156","author":"Palha","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0410","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0002-9149(99)80214-8","article-title":"Recurrence of primary (AL) amyloidosis in a transplanted heart with four-year survival","volume":"76","author":"Dubrey","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0415","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0002-9149(97)00806-0","article-title":"Effectiveness of cardiac transplantation for primary (AL) cardiac amyloidosis","volume":"79","author":"Pelosi","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0420","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0140-6736(71)90437-5","article-title":"Renal transplantation in two cases of amyloidosis","volume":"2","author":"Cohen","year":"1971","journal-title":"Lancet"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0425","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1200\/JCO.1999.17.1.262","article-title":"Prospective randomized trial of melphalan and prednisone versus vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of primary systemic amyloidosis","volume":"17","author":"Gertz","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0430","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3109\/08860229309054951","article-title":"Therapy of amyloid diseases","volume":"15","author":"Linke","year":"1993","journal-title":"Ren Fail"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0435","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM199607113350204","article-title":"A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome","volume":"335","author":"Attal","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0440","first-page":"171","article-title":"Autologous bone marrow transplantation for hematologic cancer","volume":"354B","author":"Phillips","year":"1990","journal-title":"Prog Clin Biol Res"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0445","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1445-5994.1997.tb01984.x","article-title":"Factors influencing the outcome of donor marrow transplantation in adults from less than ideal donors: Experience from two Australian centres","volume":"27","author":"Grigg","year":"1997","journal-title":"Aust N Z J Med"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0450","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1046\/j.1365-2141.1998.00527.x","article-title":"Allogeneic bone marrow transplantation for systemic AL amyloidosis","volume":"100","author":"Gillmore","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0455","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/sj.bmt.1700983","article-title":"Allogeneic bone marrow transplantation for AL amyloidosis","volume":"20","author":"Guillaume","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0460","first-page":"68","article-title":"High-dose therapy and autologous transplantation in amyloidosis-AL","volume":"78","author":"Majolino","year":"1993","journal-title":"Haematologica"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0465","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/sj.bmt.1701590","article-title":"Cells with clonal light chains are present in peripheral blood at diagnosis and in apheretic stem cell harvests of primary amyloidosis","volume":"23","author":"Perfetti","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0470","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1046\/j.1365-2141.1998.00583.x","article-title":"Detection of monoclonal plasma cells in the peripheral blood of patients with primary amyloidosis","volume":"100","author":"McElroy","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0475","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1182\/blood.V91.10.3662","article-title":"Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: Survival and responses in 25 patients","volume":"91","author":"Comenzo","year":"1998","journal-title":"Blood"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0480","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/10428190009089426","article-title":"Hematopoietic cell transplantation for primary systemic amyloidosis: What have we learned?","volume":"37","author":"Comenzo","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0485","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/sj.bmt.1702643","article-title":"Blood stem cell transplantation as therapy for primary systemic amyloidosis (AL)","volume":"26","author":"Gertz","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0490","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1089\/15258160050196678","article-title":"Fatal pulmonary toxicity related to the administration of granulocyte colony-stimulating factor in amyloidosis: A report and review of growth factor-induced pulmonary toxicity","volume":"9","author":"Gertz","year":"2000","journal-title":"J Hematother Stem Cell Res"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0495","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1046\/j.1365-2141.1998.00772.x","article-title":"Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: A report on 21 patients","volume":"101","author":"Moreau","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0500","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1365-2141.1999.01719.x","article-title":"Acute tumour lysis syndrome: A case in AL amyloidosis","volume":"107","author":"Akasheh","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0505","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/sj.bmt.1702041","article-title":"Encephalopathy complicating high-dose melphalan","volume":"24","author":"Schuh","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0510","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/sj.bmt.1702452","article-title":"Severe respiratory depression after dimethylsulphoxide-containing autologous stem cell infusion in a patient with AL amyloidosis","volume":"25","author":"Benekli","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0515","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/sj.bmt.1701330","article-title":"Gastrointestinal perforation early after peripheral blood stem cell transplantation for AL amyloidosis","volume":"22","author":"Schulenburg","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0520","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/sj.bmt.1701765","article-title":"Rapid reversal of nephrotic syndrome due to primary systemic AL amyloidosis after VAD and subsequent high-dose chemotherapy with autologous stem cell support","volume":"23","author":"Sezer","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0525","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/sj.bmt.1701925","article-title":"Improvement of amyloid-related symptoms after autologous stem cell transplantation in a patient with hepatomegaly, macroglossia and purpura","volume":"24","author":"Patriarca","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0530","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/003130200104510","article-title":"Hemorrhagic lymphadenopathy as a presenting feature of primary AL amyloidosis","volume":"32","author":"Hanley","year":"2000","journal-title":"Pathology"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0535","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1055\/s-2000-7050","article-title":"Therapy options in systemic AL-amyloidosis with renal involvement","volume":"125","author":"Hetzel","year":"2000","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0540","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/sj.bmt.1702005","article-title":"High treatment-related mortality in cardiac amyloid patients undergoing autologous stem cell transplant","volume":"24","author":"Saba","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1046\/j.1523-1755.2002.00085.x_bb0545","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/sj.bmt.1702178","article-title":"Myeloablative chemotherapy with stem cell rescue for the treatment of primary systemic amyloidosis: a status report","volume":"25","author":"Gertz","year":"2000","journal-title":"Bone Marrow Transplant"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815481463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815481463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T17:03:54Z","timestamp":1682096634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815481463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":108,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["S0085253815481463"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-1755.2002.00085.x","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2002,1]]}}}